Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
Clinical trial NCT04320277 · UNKNOWN
Trial details
- NCT number
- NCT04320277
- Sponsor
- Hospital of Prato
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-16
- Primary completion
- 2020-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.